Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 13, 2019

Total Value ($000): $392,079 (100.0% shares, 0.0% debt)

Holdings (15)

GOSS Gossamer Bio 39.3%

Value ($000) $154,227 Shares 6,953,416 Est. Cost $20.85 Unrealized -8.3%

REPL Replimune Group 19.0%

Value ($000) $74,567 Shares 5,103,455 Est. Cost $17.53 Unrealized -17.5%

— Morphic Holding 15.0%

Value ($000) $58,857 Shares 2,969,582 Est. Cost $19.82 Unrealized —

— Translate Bio 7.9%

Value ($000) $30,787 Shares 2,437,603 Est. Cost $12.65 Unrealized —

IMUX Immunic 4.0%

Value ($000) $15,731 Shares 1,371,494 Est. Cost $13.14 Unrealized 0.0%

— ObsEva 2.9%

Value ($000) $11,303 Shares 999,364 Est. Cost $9.76 Unrealized —

— Paratek Pharmaceuticals 2.6%

Value ($000) $10,376 Shares 2,600,410 Est. Cost $34.18 Unrealized —

TRVI Trevi Therapeutics 2.4%

Value ($000) $9,476 Shares 1,263,408 Est. Cost $8.61 Unrealized 0.0%

— Prevail Therapeutics 2.3%

Value ($000) $8,830 Shares 668,908 Est. Cost $13.20 Unrealized —

— FibroGen 1.5%

Value ($000) $5,903 Shares 130,646 Est. Cost $27.34 Unrealized —

— Pieris Pharmaceuticals 0.9%

Value ($000) $3,546 Shares 754,457 Est. Cost $1.83 Unrealized —

— ESSA Pharma 0.7%

Value ($000) $2,658 Shares 1,084,848 Est. Cost $3.00 Unrealized —

— Jounce Therapeutics 0.7%

Value ($000) $2,623 Shares 529,965 Est. Cost $21.99 Unrealized —

— Cidara Therapeutics 0.6%

Value ($000) $2,535 Shares 1,508,794 Est. Cost $6.73 Unrealized —

SNNAQ Sienna Biopharmaceuticals 0.2%

Value ($000) $660 Shares 758,610 Est. Cost $21.95 Unrealized -92.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GOSS	Gossamer Bio	6,953,416	$154,227	39.3%	$20.85	-8.3%	Common Stock	38341P102
REPL	Replimune Group	5,103,455	$74,567	19.0%	$17.53	-17.5%	Common Stock	76029N106
—	Morphic Holding	2,969,582	$58,857	15.0%	$19.82	—	Common Stock	61775R105
—	Translate Bio	2,437,603	$30,787	7.9%	$12.65	—	Common Stock	89374L104
IMUX	Immunic	1,371,494	$15,731	4.0%	$13.14	0.0%	Common Stock	4525EP101
—	ObsEva	999,364	$11,303	2.9%	$9.76	—	Common Stock	H5861P103
—	Paratek Pharmaceuticals	2,600,410	$10,376	2.6%	$34.18	—	Common Stock	699374302
TRVI	Trevi Therapeutics	1,263,408	$9,476	2.4%	$8.61	0.0%	Common Stock	89532M101
—	Prevail Therapeutics	668,908	$8,830	2.3%	$13.20	—	Common Stock	74140Y101
—	FibroGen	130,646	$5,903	1.5%	$27.34	—	Common Stock	31572Q808
—	Pieris Pharmaceuticals	754,457	$3,546	0.9%	$1.83	—	Common Stock	720795103
—	ESSA Pharma	1,084,848	$2,658	0.7%	$3.00	—	Common Stock	29668H708
—	Jounce Therapeutics	529,965	$2,623	0.7%	$21.99	—	Common Stock	481116101
—	Cidara Therapeutics	1,508,794	$2,535	0.6%	$6.73	—	Common Stock	171757107
SNNAQ	Sienna Biopharmaceuticals	758,610	$660	0.2%	$21.95	-92.9%	Common Stock	82622H108